But some users do report mild side effects, including: Headaches or dizziness (typically at higher doses or when stacking with GH-related peptides) Injection site irritation , redness, or swelling Nausea or GI discomfort when taken orally (more common with low-quality forms) Changes in mood or energy , including restlessness or mild anxiety These symptoms are usually temporary and resolve quickly with dosage adjustment or cycling off
Still, many individuals continue to use Ozempic for weight loss, given its accessibility and efficacy
#innovation #scienceforpatients #rheumaticdiseases Results of the phase 3b TOGETHER-PsA trial showed ixekizumab administered together with tirzepatide in comorbid overweight or obese adults with psoriatic arthritis showed clinically meaningful improvement of psoriatic disease, physical function, weight reduction, & quality-of-life, with no new safety concerns Read the full results in Arthritis & Rheumatology To view or add a comment, sign in "Investigating the Relationship Between Psoriatic Arthritis and Peyronies Disease: A Case Study Analysis" The relationship between psoriatic arthritis (PsA) and Peyronies disease (PD) remains poorly understood
[246] [245] Due to the necessary conversion of lisdexamfetamine into dextroamphetamine, levels of dextroamphetamine with lisdexamfetamine peak about one hour later than with an equivalent dose of immediate-release dextroamphetamine